pegfilgrastim
Consumer Medicine Information
This leaflet answers some common questions about Ziextenzo.
It does not contain all the available information.
It does not take the place of talking to your doctor, nurse or pharmacist.
All medicines have risks and benefits. Your doctor has prescribed Ziextenzo after considering its likely benefit to you, as well as the potential risks.
If you have any concerns about taking this medicine, talk to your doctor, nurse or pharmacist.
Keep this leaflet with your medicine. You may need to read this information again.
Ziextenzo is used following chemotherapy to help fight infection.
Some chemotherapy will reduce the number of neutrophils in your body. Although Ziextenzo is not a treatment for cancer, it does help the body to make new neutrophils. This will reduce your chance of developing infections that might require antibiotics and/or hospital stays. It may even increase your chance of receiving your chemotherapy on time and at the right dose.
Ziextenzo is a long acting form of Recombinant Human Granulocyte Colony Stimulating Factor or G-CSF. Using gene technology, Ziextenzo is produced in a specific type of bacteria, called E. coli.
G-CSF is produced in the bone marrow and assists in the production of neutrophils, which are a type of white blood cell. Neutrophils help the body fight infections by surrounding and destroying the bacteria that cause the infections.
G-CSF also helps neutrophils to do this work better.
Ask your doctor if you have any questions about why this medicine has been prescribed for you.
This medicine is available only with a doctor’s prescription.
Do not have Ziextenzo if you have an allergy to:
Symptoms of an allergic reaction may include:
Do not use Ziextenzo at the same time as your chemotherapy or radiotherapy.
Do not use Ziextenzo within 24 hours after you receive chemotherapy. This is because the chemotherapy medicine may stop Ziextenzo from increasing the number of infection – fighting neutrophils.
Do not use Ziextenzo after the expiry date (EXP) printed on the pack
Do not use Ziextenzo if the packaging is torn or shows signs of tampering.
Do not use Ziextenzo if it has been left out of the refrigerator for more than three days.
If you are not sure whether you should use Ziextenzo, talk to your doctor or pharmacist.
Tell your doctor if
Your doctor will discuss the possible risks and benefits of having Ziextenzo during pregnancy.
Your doctor will discuss the possible risks and benefits of having Ziextenzo during breastfeeding.
If you have not told your doctor about any of the above, tell them before you use Ziextenzo.
Tell your doctor if you are taking any other medicines, particularly those that may affect the blood. Also tell them about any medicines you buy without a prescription from your pharmacy, supermarket or health food shop.
Ziextenzo is given by injection, into the tissues just below the skin. This is called a subcutaneous injection.
Your doctor, nurse or pharmacist may suggest that you or your carer be taught how to give a subcutaneous injection. This will allow you to have your Ziextenzo injection at home.
Carefully follow all directions given to you by your doctor, pharmacist or nurse. They may differ from the information in this leaflet.
If you do not understand the instructions, ask your doctor, pharmacist or nurse for help.
To help avoid possible infections and to ensure that you use the medicine correctly, it is important that you follow these instructions.
Read ALL the way through these instructions before injecting. It is important not to try to inject yourself until you have been trained by your doctor, nurse or pharmacist. The carton contains ZIEXTENZO® pre-filled syringe individually sealed in a plastic blister.
Your ZIEXTENZO® pre-filled syringe with needle guard
After the medicine has been injected, the needle guard will be activated to cover the needle. The needle guard is intended to protect healthcare professionals, caregivers and patients from accidental needle sticks after the injection.
What you additionally need for your injection:
Important safety information
Caution: Keep the pre-filled syringe out of the sight and reach of children.
Storage of the ZIEXTENZO® pre-filled syringe
The injection site
The injection site is the place on the body where you are going to use the pre-filled syringe.
If a caregiver is giving you the injection, the outer upper arms may also be used.
Preparing the ZIEXTENZO® pre-filled syringe ready for use
Device ACTIVATED – DO NOT USE
Device READY TO BE USED
How to use the ZIEXTENZO® pre-filled syringe
Carefully pull the needle cap straight off. You may see a drop of liquid at the end of the needle. This is normal.
Gently pinch the skin at the injection site and insert the needle as shown. Push the needle all the way in to ensure that the medication can be fully administered.
Holding the pre-filled syringe as shown, slowly depress the plunger as far as it will go so that the plunger head is completely between the needle guard wings.
Keep the plunger pressed fully down while you hold the syringe in place for 5 seconds.
Keep the plunger fully depressed while you carefully pull the needle straight out from the injection site and let it go off your skin.
Slowly release the plunger and allow the syringe needle guard to automatically cover the exposed needle.
There may be a small amount of blood at the injection site. You can press a cotton ball or gauze onto the injection site and hold it for 10 seconds. Do not rub the injection site. You may cover the injection site with a small adhesive bandage, if needed.
Disposal instructions
Dispose of the used syringe in a sharps container (closable, puncture resistant container).
Do not throw away any medicines via wastewater or household waste. Ask your doctor or pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. Any unused product or waste material should be disposed of in accordance with local requirements.
The usual dose is one subcutaneous injection 24 hours after the end of each chemotherapy cycle.
Use Ziextenzo 24 hours after the end of each chemotherapy cycle.
Your doctor will tell you when to begin your treatment and when to stop.
If you miss your scheduled dose, talk to your doctor, nurse or pharmacist as soon as possible.
If you inject more Ziextenzo than you need, talk to your doctor, nurse or pharmacist.
If you feel unwell in any way you talk to your doctor, nurse or pharmacist immediately.
Watch for any signs or symptoms of infection.
There are many ways an infection may show itself.
Symptoms of an infection include:
Go straight to your hospital if you develop any of these symptoms.
If you are about to be started on any new medicine, tell your doctor, nurse and pharmacist that you are using Ziextenzo.
Tell any other doctors, dentists and pharmacists who treat you that you are taking this medicine.
Tell your doctor immediately if you become pregnant while taking this medicine.
Keep all of your doctor’s appointments so that your health can be monitored. Your doctor may order blood tests to check the levels of infection-fighting neutrophils and other blood cells.
Do not use Ziextenzo to treat any other complaints unless your doctor tells you to.
Do not give Ziextenzo to anyone else, even if they have the same condition as you.
Tell your doctor, nurse or pharmacist as soon as possible if you have any problems while using Ziextenzo, even if you do not think the problems are connected with the medicine or are not listed in this leaflet.
All medicines can have side effects. Some side effects may be serious and need medical attention. Other side effects are minor and are likely to be temporary.
You may also experience side effects caused by other medicines you are taking at the same time as Ziextenzo.
Your doctor has weighed the risks of using this medicine against the benefits they expect it will have for you.
Do not be alarmed by this list of possible side effects. You may not experience any of them.
Ask your doctor, nurse or pharmacist to answer any questions you may have.
Tell your doctor if you notice any of the following and they worry you:
Tell your doctor immediately if you notice any of the following:
The above list includes serious side effects that may require medical attention.
Tell your doctor immediately, or go to Accident and Emergency at your nearest hospital if you notice any of the following:
These may be serious side effects of Ziextenzo. You may need urgent medical attention.
Serious side effects are rare or uncommon.
If any of the following happen, stop taking Ziextenzo and go straight to hospital, as you may need urgent medical attention:
These are very serious side effects. If you have them you may have had a serious allergic reaction to Ziextenzo. You may need urgent medical attention or hospitalisation.
Tell your doctor if you notice anything that worries you or that is making you feel unwell.
Other side effects not listed above may occur in some people.
Keep Ziextenzo in a refrigerator at a temperature of 2°C to 8°C.
Do not freeze.
Do not use Ziextenzo if you think it has been frozen. Exposure to room temperature of up to 3 days will not harm Ziextenzo.
Keep your medicine in its pack. Protect it from light.
Keep it where children cannot reach it.
Once you have injected Ziextenzo, do not put the grey needle cap back on the used syringe.
Discard the used syringe into an approved, puncture-resistant sharps container and keep it out of the reach of children.
Never put the used syringes into your normal household rubbish bin.
Dispose of the full puncture-resistant sharps container as instructed by your doctor, nurse or pharmacist.
Ziextenzo is a clear, colourless solution. It is supplied in a carton as a pre-filled syringe with an automatic needle guard.
Active ingredient: 6 mg pegfilgrastim
Inactive ingredients:
Ziextenzo does not contain lactose, gluten, tartrazine or any other azo dyes.
Sandoz Pty Ltd
ABN 60 075 449 553
54 Waterloo Road
Macquarie Park NSW 2113
Telephone: 1800 726 369
Web site: www.sandoz.com.au
This leaflet was prepared in January 2021.
Australian Registration Number:
Pre-filled syringe with automatic needle guard AUST R 308367
® Registered trademark.
Published by MIMS March 2021
ncG1vNJzZmilqZm%2Fb6%2FOpmWarV%2BisqW1wqKlnqtfr7amxNOepbOnXw%3D%3D